Monogram Health

Monogram Health is a value-based specialty medical provider that delivers in-home, evidence-based care and benefit management services to patients living with polychronic conditions, including chronic kidney disease and end-stage renal disease. Its clinical teams span nephrology, cardiology, endocrinology, pulmonology, behavioral health and palliative care, and include physicians, nurse practitioners, registered nurses, social workers, pharmacists and dietitians who work alongside a patient's existing doctors. Services include in-home physician and nurse practitioner visits, in-home medical tests, medication review and prescribing, personalized treatment planning, 24/7/365 telephone access to a clinician, and support for social needs such as food access, healthy meal planning, housing, transportation and financial assistance.

Alongside direct care delivery, the company offers a technology-driven set of evidence-based clinical services to health plan and provider partners, including complex case and disease management, utilization management and medication therapy management. Its approach uses remote biometric monitoring, algorithm-based risk prediction and specialist review, with care planning that supports transitions to dialysis, palliative care or preemptive kidney transplant where appropriate. The company states its model improves patient outcomes and quality of life while reducing medical costs across the care continuum.

Founding story

Monogram Health was co-founded by Mike Uchrin, who serves as CEO, with Senator Bill Frist, M.D., who chairs the board and is a partner at Frist Cressey Ventures; Frist has described the company as having been founded with a particular focus on health equity, noting that kidney disease disproportionately affects disadvantaged communities and communities of color.

Business model

Monogram Health contracts with health plans and risk-bearing providers under value-based partnerships covering all insurance products, and delivers in-home clinical care plus benefit management services such as complex case and disease management, utilization management and medication therapy management. Care is presented to patients as a covered benefit under many health plans, with cost sharing applying only to certain physician, nurse practitioner or specialist visits depending on the plan.

Revenue derives from value-based arrangements with health plans and risk-bearing provider organizations, under which Monogram Health is engaged to manage the care of members with chronic kidney disease and other chronic conditions; patient services are billed through the health plan benefit rather than charged directly to most patients.

Traction

As of January 2023 the company reported serving patients in nearly 4,000 U.S. cities across 34 states. Company materials cite more than 220,000 people served each year and over 100,000 patients across most of the continental United States, and report that its patients show higher rates of controlled A1C and controlled blood pressure than national averages. Fierce Healthcare, citing Crunchbase, reported cumulative funding of $557 million following the January 2023 raise.

Latest developments

Following the January 2023 growth round, Monogram Health said it would use proceeds to accelerate deployment of its in-home kidney and polychronic care model and its clinical services suite. Company materials dated 2025 cite socioeconomic gaps addressed during that year and patient reviews from September and October 2025, and describe an operating care center with weekday and weekend hours.